1,112
Views
21
CrossRef citations to date
0
Altmetric
Review

Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action

&
Pages 161-175 | Published online: 09 Jan 2014

Figures & data

Figure 1. Possible mechanisms of neuroprotection mediated by α2-adrenergic agonists.

α2-agonists such as brimonidine initiate multiple possible protective cascades. Direct binding of the α2-receptor on RGCs could promote Bcl-mediated anti-apoptotic cascades, while binding to receptors expressed by glial or pigment epithelial cells could induce trophic signaling involving BDNF and bFGF, and their respective receptors.

bFGF: Basic FGF; NMDA-R: NMDA receptor; RGC: Retinal ganglion cell.

Figure 1. Possible mechanisms of neuroprotection mediated by α2-adrenergic agonists.α2-agonists such as brimonidine initiate multiple possible protective cascades. Direct binding of the α2-receptor on RGCs could promote Bcl-mediated anti-apoptotic cascades, while binding to receptors expressed by glial or pigment epithelial cells could induce trophic signaling involving BDNF and bFGF, and their respective receptors.bFGF: Basic FGF; NMDA-R: NMDA receptor; RGC: Retinal ganglion cell.
Figure 2. Putative neuroprotective actions of β-receptor antagonists.

Based on known expression patterns, β-receptor antagonists could bind channels in presynaptic circuits to reduce the release of glutamate and postsynaptic activation of NMDA receptors on RGCs. Antagonists could also exert influence on receptors expressed by vascular elements, leading to increased blood supply and reduced ischemia-related stress. Finally, certain β-receptor antagonists upregulate expression of BDNF in retinal glia.

NMDA-R: NMDA receptor; RGC: Retinal ganglion cell; TRKB: Tyrosine receptor kinase B.

Figure 2. Putative neuroprotective actions of β-receptor antagonists.Based on known expression patterns, β-receptor antagonists could bind channels in presynaptic circuits to reduce the release of glutamate and postsynaptic activation of NMDA receptors on RGCs. Antagonists could also exert influence on receptors expressed by vascular elements, leading to increased blood supply and reduced ischemia-related stress. Finally, certain β-receptor antagonists upregulate expression of BDNF in retinal glia.NMDA-R: NMDA receptor; RGC: Retinal ganglion cell; TRKB: Tyrosine receptor kinase B.
Figure 3. Possible neuroprotective mechanisms of prostaglandin F2 receptor agonists on retinal ganglion cells.

Evidence suggests a role for prostaglandin agonists in reducing excitotoxic stress. Direct binding of prostaglandin receptors on RGCs could reduce COX-2-mediated induction of nitric oxide synthase.

NMDA-R: NMDA receptor; RGC: Retinal ganglion cell.

Figure 3. Possible neuroprotective mechanisms of prostaglandin F2 receptor agonists on retinal ganglion cells.Evidence suggests a role for prostaglandin agonists in reducing excitotoxic stress. Direct binding of prostaglandin receptors on RGCs could reduce COX-2-mediated induction of nitric oxide synthase.NMDA-R: NMDA receptor; RGC: Retinal ganglion cell.
Figure 4. Interaction of glutamate with NMDA receptors.

In many neurodegenerative conditions, excessive glutamate release from presynaptic terminals binds to postsynaptic NMDA-Rs, depolarizing the postsynaptic membrane through removal of the Mg2+ block. Subsequent influx and build-up of excess calcium leads to excitotoxicity and neuronal apoptosis.

NMDA-R: NMDA receptor.

Figure 4. Interaction of glutamate with NMDA receptors.In many neurodegenerative conditions, excessive glutamate release from presynaptic terminals binds to postsynaptic NMDA-Rs, depolarizing the postsynaptic membrane through removal of the Mg2+ block. Subsequent influx and build-up of excess calcium leads to excitotoxicity and neuronal apoptosis.NMDA-R: NMDA receptor.

Activity Evaluation: Where 1 is strongly disagree and 5 is strongly agree

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.